110 results
8-K
EX-99.2
GLYC
GlycoMimetics Inc
6 May 24
Results of Operations and Financial Condition
4:01pm
prognostic for survival Effect independent of age, subtype, timing, method MRD Negativity and HSCT Both Favorably Prognostic 11 Overall Survival by MRD
8-K
GLYC
GlycoMimetics Inc
2 May 24
Amendments to Articles of Incorporation or Bylaws
8:30am
Rachel King
Broker Non-Votes: 13,231,353
Proposal No. 2: Stockholders ratified the appointment of Ernst & Young LLP as independent registered public
S-8
GLYC
GlycoMimetics Inc
27 Mar 24
Registration of securities for employees
4:01pm
under 2013 Equity Incentive Plan.
Opinion of Cooley LLP.
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm.
Consent
S-8
EX-23.1
GLYC
GlycoMimetics Inc
27 Mar 24
Registration of securities for employees
4:01pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement
PRE 14A
7zypi81i
22 Mar 24
Preliminary proxy
5:00pm
8-K
EX-99.1
fxfuedfxz8p9ay
1 Mar 24
Regulation FD Disclosure
9:16am
8-K
EX-99.1
olseid arn1yzr
3 Nov 23
GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2023
8:35am
8-K
uz2wo
22 May 23
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
EX-99.1
gh9o0mtwco8cswqxpu
3 May 23
GlycoMimetics Reports Highlights and Financial Results for First Quarter 2023
8:36am